PHP
HAE icon

Parkman Healthcare Partners’s Haemonetics HAE Stock Holding History

Parkman Healthcare Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-76,079
Closed -$6.29M – 98
2024
Q2 		$6.29M Sell
76,079
-14,883
-16% -$1.31M 0.84% 43
2024
Q1 		$7.76M Buy
90,962
+21,022
+30% +$1.65M 0.95% 39
2023
Q4 		$5.98M Sell
69,940
-19,022
-21% -$1.64M 0.84% 37
2023
Q3 		$7.97M Sell
88,962
-26,099
-23% -$2.33M 1.46% 20
2023
Q2 		$9.8M Sell
115,061
-25,679
-18% -$2.17M 1.7% 20
2023
Q1 		$11.6M Buy
140,740
+8,362
+6% +$677K 2.53% 7
2022
Q4 		$10.4M Buy
132,378
+16,581
+14% +$1.33M 2.77% 8
2022
Q3 		$8.57M Buy
115,797
+90,797
+363% +$6.52M 2.44% 10
2022
Q2 		$1.63M Buy
+25,000
New +$1.48M 0.6% 46
2021
Q2 		– Sell
-17,500
Closed -$1.94M – 88
2021
Q1 		$1.94M Buy
+17,500
New +$2.17M 0.45% 57
2020
Q3 		– Sell
-30,147
Closed -$2.7M – 88
2020
Q2 		$2.7M Buy
30,147
+15,000
+99% +$1.52M 0.76% 46
2020
Q1 		$1.51M Sell
15,147
-45,103
-75% -$4.89M 0.7% 46
2019
Q4 		$6.92M Buy
+60,250
New +$7.29M 2% 21

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Parkman Healthcare Partners's HAE Position: Q3 2024 in Review

Parkman Healthcare Partners sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 76,079 shares — an estimated $6.29M sold.

Parkman Healthcare Partners first reported a position in HAE in Q4 2019 and held it in 13 quarters. The position peaked at $11.6M in Q1 2023. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Parkman Healthcare Partners reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 76,079 Haemonetics shares in Q3 2024, an estimated $6.29M.
  • Parkman Healthcare Partners first reported a position in Haemonetics in Q4 2019 and held it in 13 quarters.
  • Parkman Healthcare Partners's Haemonetics position peaked at $11.6M in Q1 2023.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Parkman Healthcare Partners's 13F filing for Q3 2024, filed 14 Nov 2024.